Contravisory Investment Management, Inc. Laboratory Corp Of America Holdings Transaction History

Contravisory Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 08, 2019	SELL	$123.7 - $156.3 $4.35 Million - $5.5 Million	-35,170 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$120.82 - $174.09 $73,700 - $106,194	-610 Reduced 1.7%	35,170 $4.44 Million
Q3 2018 Oct 11, 2018	SELL	$167.67 - $188.27 $220,989 - $248,139	-1,318 Reduced 3.55%	35,780 $6.21 Million
Q2 2018 Jul 11, 2018	SELL	$160.33 - $189.41 $75,996 - $89,780	-474 Reduced 1.26%	37,098 $6.66 Million
Q1 2018 Apr 09, 2018	SELL	$161.53 - $178.11 $233,249 - $257,190	-1,444 Reduced 3.7%	37,572 $6.08 Million
Q4 2017 Jan 18, 2018	SELL	$147.99 - $163.95 $562,509 - $623,173	-3,801 Reduced 8.88%	39,016 $6.22 Million
Q3 2017 Oct 12, 2017	BUY	$149.47 - $160.56 $6.4 Million - $6.87 Million	42,817	42,817 $6.46 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.